Roles of GSK3 in metabolic shift toward abnormal anabolism in cell senescence

Annals of the New York Academy of Sciences

Volumn 1201, Issue , 2010, Pages 65-71

  Kim, You Mie ^a,b   Seo, Yong Hak ^a,b   Park, Chan Bae ^a   Yoon, Soo Han ^a   Yoon, Gyesoon ^a,b  

^a Ajou University   (South Korea)

^b Ajou University School of Medicine   (South Korea)

Author keywords

cell senescence; GSK3; metabolic alteration; senescent phenotypes

Indexed keywords

ENZYME INHIBITOR; GLYCOGEN; GLYCOGEN SYNTHASE KINASE 3; STEROL REGULATORY ELEMENT BINDING PROTEIN 1; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR ELF 2; UNCLASSIFIED DRUG; FLUORESCENT DYE; REACTIVE OXYGEN METABOLITE; SREBF1 PROTEIN, HUMAN;

BIOSYNTHESIS; CELL ORGANELLE; CELL VOLUME; CONFERENCE PAPER; CYTOTOXICITY; DISORDERS OF MITOCHONDRIAL FUNCTIONS; GLYCOGEN SYNTHESIS; HUMAN; LIPOGENESIS; PHENOTYPE; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; SENESCENCE; ANIMAL; BIOLOGICAL MODEL; CELL AGING; CELL LINE; METABOLISM; MITOCHONDRION; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHOSPHORYLATION; PHYSIOLOGY; REVIEW;

ANIMALS; CELL AGING; CELL LINE; FLUORESCENT DYES; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MITOCHONDRIA; MODELS, BIOLOGICAL; OXIDATIVE STRESS; OXYGEN CONSUMPTION; PHENOTYPE; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; STEROL REGULATORY ELEMENT BINDING PROTEIN 1;

EID: 77955293654     PISSN: 00778923     EISSN: 17496632     Source Type: Book Series    
DOI: 10.1111/j.1749-6632.2010.05617.x     Document Type: Conference Paper

References (38)

1. Campisi, J. et al. 2001. Cellular senescence, cancer and aging: the telomere connection. Exp. Gerontol. 36: 1619-1637.
2. Matsumura, T., Z. Zerrudo & L. Hayflick. 1979. Senescent human diploid cells in culture: survival, DNA synthesis and morphology. J. Gerontol. 34: 328-334.
3. Richter, C. et al. 1995. Oxidants inmitochondria: fromphysiology to diseases. Biochim. Biophys. Acta. 1271: 67-74.
4. Finkel, T. & N.J. Holbrook. 2000. Oxidants, oxidative stress and the biology of ageing. Nature 408: 239-247.
5. Raha, S. & B.H. Robinson. 2000.Mitochondria, oxygen free radicals, disease and ageing. Trends Biochem. Sci. 25: 502-508.
6. Yoon, Y.S. et al. 2003.Complex II defect via down-regulation of iron-sulfur subunit induces mitochondrial dysfunction and cell cycle delay in iron chelation-induced senescenceassociated growth arrest. J. Biol. Chem. 278: 51577-51586.
7. Chomyn, A. & G. Attardi. 2003. MtDNAmutations in aging and apoptosis. Biochem. Biophys. Res. Commun. 304: 519-529.
8. Hayakawa, M. et al. 1993. Age-associated damage in mitochondrial DNA in human hearts. Mol. Cell. Biochem. 119: 95-103.
9. Trifunovic, A. et al. 2004. Premature ageing in mice expressing defective mitochondrial DNA polymerase. Nature 429: 417-423.
10. Yoon, Y.S. et al. 2006. Formation of elongated giant mitochondria in DFO-induced cellular senescence: involvement of enhanced fusion process through modulation of Fis1. J. Cell. Physiol. 209: 468-480.
11. Yoon, Y.S. et al. 2004. Mitochondrial dysfunction via disruption of complex II activity during iron chelation-induced senescence-like growth arrest of Chang cells. Ann. N.Y. Acad. Sci. 1011: 123-132.
12. Yoon, Y.S. et al. 2005. TGF 1 induces prolonged mitochondrial ROS generation through decreased complex IV activity with senescent arrest in Mv1Lu cells. Oncogene 24: 1895-1903.
13. Seo, Y.H. et al. 2008. Enhanced glycogenesis is involved in cellular senescence via GSK3/GS modulation. Aging Cell 7: 894-907.
14. Embi, N., D.B. Rylatt & P. Cohen. 1980. Glycogen synthase kinase-3 from rabbit skeletal muscle. Separation from cyclic AMP-dependent protein kinase and phosphorylase kinase. Eur. J. Biochem. 107: 519-527.
15. Cohen, P. & S. Frame. 2001. The renaissance of GSK3. Nat. Rev. Mol. Cell Biol. 2: 769-776.
16. Rylatt, D.B. et al. 1980. Glycogen synthase from rabbit skeletal muscle. Amino acid sequence at the sites phosphorylated by glycogen synthase kinase-3, and extension of the N-terminal sequence containing the site phosphorylated by phosphorylase kinase. Eur. J. Biochem. 107: 529-537.
17. Forde, J.E. & T.C. Dale. 2007. Glycogen synthase kinase 3: a key regulator of cellular fate. Cell Mol. Life Sci. 64: 1930-1944.
18. Eldar-Finkelman, H. & R. Ilouz. 2003. Challenges and oppotunities with glycogen synthase kinase-3 inhibitors for insulin resistance and Type 2 diabetes treatment. Expert Opin. Investig. Drugs 12: 1511-1519.
19. Takashima, A. 2006. GSK-3 is essential in the pathogenesis of Alzheimer's disease. J. Alzheimers. Dis. 9: 309-317.
20. Chang, B-D. et al. 1999. A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents. Cancer Res. 59: 3761-3767.
21. Cristofalo, V.J. & D. Kritchevsky. 1969. Cell size and nucleic acid content in the diploid human cell line WI-38 during aging. Med. Exp. Int. J. Exp. Med. 19: 313-320.
22. Greenberg, S.B., G.L. Grove & V.J. Cristofalo. 1977. Cell size in aging monolayer cultures. In Vitro 13: 297-300.
23. Wang, E. & D. Gundersen. 1984. Increased organization of cytoskeleton accompanying the aging of human fibroblasts in vitro. Exp. Cell Res. 154: 191-202.
24. Mamane, Y. et al. 2006. mTOR, translation initiation and cancer. Oncogene 25: 6416-6422.
25. Wang, Y., A. Meng & D. Zhou. 2004. Inhibition of phosphatidylinostol 3-kinase uncouplesH2O2-induced senescent phenotype and cell cycle arrest in normal human diploid fibroblasts. Exp. Cell Res. 298: 188-196.
26. Robbins, E., E.M. Levine & H. Eagle. 1970. Morphologic changes accompanying senescence of cultured human diploid cells. J. Exp. Med. 131: 1211-1222.
27. Lee, H.C. et al. 2002. Increase in mitochondrial mass in human fibroblasts under oxidative stress and during replicative cell senescence. J. Biomed. Sci. 9: 517-526.
28. Passos, J.F. et al. 2007. Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. 5: e110.
29. Lee, H.C. et al. 1998. Aging- and smoking associated alteration in the relative content of mitochondrial DNA in human lung. FEBS Lett. 441: 292-296.
30. Wei, Y.H. et al. 2001. Increases of mitochondrial mass and mitochondrial genome in association with enhanced oxidative stress in human cells harboring 4, 977 BPdeleted mitochondrial DNA. Ann. N. Y. Acad. Sci. 928: 97-112.
31. Kim, K.H. et al. 2004. Regulatory role of glycogen synthase kinase 3 for transcriptional activity of ADD1/SREBP1c. J. Biol. Chem. 279: 51999-52006.
32. Sundqvist, A. et al. 2005. Control of lipid metabolism by phosphorylation-dependent degradation of the SREBP family of transcription factors by SCF(Fbw7). Cell Metab. 1: 379-391.
33. Grune,T. et al. 2004. Decreased proteolysis caused by protein aggregates, inclusion bodies, plaques, lipofuscin, ceroid, and 'aggresomes' during oxidative stress, aging, and disease. Int. J. Biochem. Cell Biol. 36: 2519-2530.
34. Villani, G.&G.Attardi. 2001. In vivo measurements of respiration control by cytochrome c oxidase and in situ analysis of oxidative phosphorylation. Methods Cell Biol. 65: 119-131.
35. Dimri, G.P. et al. 1995. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 92, 9363-9367.
36. Yoon, G. et al. 2002. Iron chelation-induced senescence-like growth arret in hepatocyte cell lines: association of TGF-1-mediated p27Kip1 expression. Biochem. J. 366: 613-621.
37. Bligh, E.G. &W.J. Dyer. 1959. A rapid method of total lipid extraction and purification. Can. J. Biochem. Physiol. 37: 911-917.
38. Kupke, I.R. & S. Zeugner. 1978. Quantitative highperformance thin-layer chromatography of lipids in plasma and liver homogenates after direct application of 0.5-microliter samples to the silica-gel layer. J. Chromatogr. 146: 261-271.